Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 7,976,789
- Share change
- +89,158
- Total reported value
- $174,812,982
- Price per share
- $21.99
- Number of holders
- 38
- Value change
- +$2,372,202
- Number of buys
- 28
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.4%
|
2,128,719
|
$44,980,000 | — | 30 Sep 2016 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.5%
|
1,581,076
|
$33,408,000 | — | 30 Sep 2016 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.3%
|
800,000
|
$16,904,000 | — | 30 Sep 2016 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.2%
|
754,411
|
$15,941,000 | — | 30 Sep 2016 | |
| BVF INC/IL |
13F
|
Company |
0.6%
|
375,000
|
$7,924,000 | — | 30 Sep 2016 | |
| Foresite Capital Management III, LLC |
13F
|
Company |
0.55%
|
346,281
|
$6,285,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.33%
|
206,455
|
$4,362,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.23%
|
142,468
|
$3,011,000 | — | 30 Sep 2016 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.2%
|
123,804
|
$2,616,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
92,820
|
$1,960,000 | — | 30 Sep 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.11%
|
66,262
|
$1,400,000 | — | 30 Sep 2016 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
61,121
|
$1,292,000 | — | 30 Sep 2016 | |
| Spark Investment Management LLC |
13F
|
Company |
0.07%
|
42,100
|
$889,000 | — | 30 Sep 2016 | |
| Graticule Asia Macro Advisors LLC |
13F
|
Company |
0.05%
|
31,827
|
$673,000 | — | 30 Sep 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.05%
|
28,898
|
$611,000 | — | 30 Sep 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
20,137
|
$425,000 | — | 30 Sep 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.03%
|
16,924
|
$358,000 | — | 30 Sep 2016 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
16,100
|
$340,000 | — | 30 Sep 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
14,202
|
$301,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
13,340
|
$282,000 | — | 30 Sep 2016 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
10,964
|
$232,000 | — | 30 Sep 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
10,093
|
$213,000 | — | 30 Sep 2016 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.01%
|
8,037
|
$170,000 | — | 30 Sep 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
2,605
|
$55,000 | — | 30 Sep 2016 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,400
|
$50,000 | — | 30 Sep 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,108
|
$45,000 | — | 30 Sep 2016 | |
| Nationwide Fund Advisors |
13F
|
Company |
0%
|
2,101
|
$44,000 | — | 30 Sep 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
1,270
|
$26,000 | — | 30 Sep 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,069
|
$23,000 | — | 30 Sep 2016 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
621
|
$13,000 | — | 30 Sep 2016 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
271
|
$5,726 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
200
|
$4,000 | — | 30 Sep 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
200
|
$4,000 | — | 30 Sep 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
177
|
$4,000 | — | 30 Sep 2016 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q4 2016
As of 31 Dec 2016,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,976,789 shares.
The largest 10 holders included
FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pharmstandard International S.A., Cormorant Asset Management, LLC, RA CAPITAL MANAGEMENT, LLC, Foresite Capital Management III, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
34
Q4 2016 holders
38
Holder diff
4
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.